Zoetis reported $6.29B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
AbbVie USD 37.48B 3.81B Sep/2026
Align Technology USD 2.73B 63.03M Sep/2026
Bayer EUR 39.6B 5.96B Sep/2026
Bristol-Myers Squibb USD 29.77B 1.19B Sep/2026
Charles River Laboratories USD 1.54B 5.92M Sep/2026
Coherus Biosciences USD 133.79M 72.25M Jun/2026
Dentsply International USD 1.98B 50M Sep/2026
Eli Lilly USD 65.26B 591M Sep/2026
Henry Schein USD 4.78B 176M Sep/2026
Idexx Laboratories USD 1.5B 9.48M Sep/2026
Illumina USD 3.04B 201M Sep/2026
IQVIA Holdings USD 6.45B 225M Sep/2026
J&J USD 56.35B 3.42B Sep/2026
Laboratory Of America USD 3.97B 151.3M Sep/2026
Merck USD 38.94B 2.26B Sep/2026
Neogen USD 582.5M 22.1M Jun/2026
Pacira USD 10.3B 9.68B Sep/2026
Perrigo USD 2.4B 49.7M Sep/2026
Pfizer USD 45.01B 3.65B Sep/2026
Phibro Animal Health USD 945.17M 9.67M Sep/2026
Quest Diagnostics USD 3.12B 273M Sep/2026
Sanofi EUR 33.21B 1.68B Sep/2026
Sanofi EUR 31.52B 1.36B Jun/2026
Zoetis USD 6.29B 63M Sep/2026